RBC distribution width predicts thrombosis risk in polycythemia vera-Reference-Cited by-同舟云学术

RBC distribution width predicts thrombosis risk in polycythemia vera

Published:2021-09-08 Issue:2 Volume:36 Page:566-568
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Liu Dan,Li Bing,Xu Zefeng,Zhang Peihong,Qin Tiejun,Qu Shiqiang,Pan Lijuan,Sun Xiujuan,Shi Zhongxun,Huang Huijun,Wang Huijun,Gale Robert Peter,Xiao Zhijian^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

https://www.nature.com/articles/s41375-021-01410-2.pdf

Reference14 articles.

1. Cerquozzi S, Barraco D, Lasho T, Finke C, Hanson CA, Ketterling RP, et al. Risk factors for arterial versus venous thrombosis in polycythemia vera: a single center experience in 587 patients. Blood Cancer J. 2017;7:662.

2. Barbui T, Carobbio A, Rumi E, Finazzi G, Gisslinger H, Rodeghiero F, et al. In contemporary patients with polycythemia vera, rates of thrombosis and risk factors delineate a new clinical epidemiology. Blood. 2014;124:1822.

3. Landolfi R, Marchioli R, Kutti J, Gisslinger H, Tognoni G, Patrono C, et al. Efficacy and safety of low-dose aspirin in polycythemia vera. N Engl J Med. 2004;350:114–24.

4. De Stefano V, Rossi E, Carobbio A, Ghirardi A, Betti S, Finazzi G, et al. Hydroxyurea prevents arterial and late venous thrombotic recurrences in patients with myeloproliferative neoplasms but fails in the splanchnic venous district. Pooled analysis of 1500 cases. Blood Cancer J. 2018;8:112.

5. Vannucchi AM, Antonioli E, Guglielmelli P, Longo G, Pancrazzi A, Ponziani V, et al. Prospective identification of high-risk polycythemia vera patients based on JAK2V617F allele burden. Leukemia. 2007;21:1952–59.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic Inflammatory Index in Polycythemia Vera and Its Prognostic Implications;Journal of Clinical Medicine;2024-07-30

2. Red cell distribution width and prognosis in myelofibrosis patients treated with ruxolitinib;Annals of Hematology;2024-06-12

3. Evaluation of Absolute Neutrophil, Lymphocyte and Platelet Count and Their Ratios as Predictors of Thrombotic Risk in Patients with Prefibrotic and Overt Myelofibrosis;Life;2024-04-17

4. Establishment of Prediction Model for Severe Hypertriglyceridemic Acute Pancreatitis Based on Early Laboratory Indicators;Intensive Care Research;2024-03-14

5. Changes in RDW according to prognostic predictors in newly diagnosed multiple myeloma;Scientific Reports;2024-02-03